PET imaging of beta-secretase 1 in the human brain: radiation dosimetry, quantification, and test-retest examination of [18F]PF-06684511.

European Journal of Nuclear Medicine and Molecular Imaging
Ryosuke ArakawaAndrea Varrone

Abstract

Beta-secretase 1 (BACE1) enzyme is implicated in the pathophysiology of Alzheimer's disease. [18F]PF-06684511 is a positron emission tomography (PET) radioligand for imaging BACE1. Despite favorable brain kinetic properties, the effective dose (ED) of [18F]PF-06684511 estimated in non-human primates was relatively high. This study was therefore designed to evaluate the whole-body distribution, dosimetry, quantification, and test-retest reliability of imaging brain BACE1 with [18F]PF-06684511 in healthy volunteers. Five subjects were studied for the dosimetry study. Whole-body PET was performed for 366 min with 4 PET-CT sessions. Estimates of the absorbed radiation dose were calculated using the male adult model. Eight subjects participated in the test-retest study. Brain PET measurements were conducted for 123 min with an interval of 5 to 19 days between test and retest conditions. The total distribution volume (VT) was estimated with one-tissue (1T), two-tissue (2T), compartment model (CM), and graphical analysis. Test-retest variability (TRV) and intraclass correlation coefficient (ICC) of VT were calculated as reliability measures. In the dosimetry study, the highest uptake was found in the liver (25.2 ± 2.3 %ID at 0.5 h) an...Continue Reading

References

Sep 1, 1990·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·J LoganS J Gatley
Jan 24, 2009·Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine·Graeme J O'KeefeChristopher C Rowe
Apr 18, 2009·Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine·Michel KooleKoen Van Laere
May 14, 2009·European Journal of Nuclear Medicine and Molecular Imaging·Andrea VarroneLars Farde
Jul 23, 2013·European Journal of Nuclear Medicine and Molecular Imaging·Paolo Zanotti-FregonaraRobert B Innis
Mar 22, 2014·Journal of Neurochemistry·Robert VassarStefan F Lichtenthaler
Aug 22, 2015·European Journal of Nuclear Medicine and Molecular Imaging·K CollsteS Cervenka
Oct 14, 2017·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Gerald Koelsch
Jan 13, 2018·Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine·Julie OttoySteven Staelens
Jun 9, 2018·Frontiers in Chemistry·Judite R M CoimbraJorge A R Salvador
Sep 29, 2018·Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine·Michel KooleKoen Van Laere
Dec 12, 2018·Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine·Akihiro TakanoChrister Halldin
Oct 30, 2019·Expert Opinion on Investigational Drugs·Bruno P Imbimbo, Mark Watling

❮ Previous
Next ❯

Citations

Jul 9, 2020·European Journal of Nuclear Medicine and Molecular Imaging·Michel KooleTonya M Gilbert
Jan 5, 2021·Journal of Biochemical and Molecular Toxicology·Tauqeerunnisa Syeda, Jason R Cannon

❮ Previous
Next ❯

Software Mentioned

Logan graphical analysis ( GA )
MATLAB
OLINDA
EXM
SPM5
Logan GA

Related Concepts

Related Feeds

Alzheimer's Disease: Neuroimaging

Neuroimaging can help identify pathological hallmarks of Alzheimer's disease (AD). Here is the latest research on neuroimaging modalities, including magnetic resonance imaging and positron emission tomography, in AD.

Arrhythmia

Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.